PT - JOURNAL ARTICLE AU - AL Voskamp AU - ML Gerdes AU - R Menafra AU - E Duijster AU - SM Kielbasa AU - T Groot Kormelink AU - T Tak AU - K Stam AU - NW de Jong AU - RW Hendricks AU - SL Kloet AU - M Yazdanbakhsh AU - EC de Jong AU - R Gerth van Wijk AU - HH Smits TI - Proteo-transcriptomic profiling of nasal mononuclear phagocytic system cells in human controlled allergen challenge AID - 10.1101/2020.09.09.20189886 DP - 2020 Jan 01 TA - medRxiv PG - 2020.09.09.20189886 4099 - http://medrxiv.org/content/early/2020/09/10/2020.09.09.20189886.short 4100 - http://medrxiv.org/content/early/2020/09/10/2020.09.09.20189886.full AB - Immune homeostasis is essential to protect mucosal airway surfaces from unnecessary and damaging inflammation against inhaled harmless environmental antigens, such as allergens. However, in allergic individuals this protective homeostatic response seems to be absent. Innate cells that are part of the mononuclear phagocytic system (MPS) play an important role in these processes. Most of our knowledge on allergic immune responses comes from animal models or from peripheral blood immune responses in humans. Information on tissue-specific responses in humans is scarce, however allergen-specific immune responses are initiated locally and this information is therefore crucial for the development of novel therapies. In this study we performed mass-cytometry proteomics and single cell RNA sequencing on immune cells from nasal biopsies of allergic rhinitis subjects and non-allergic controls, before and three days after repeated nasal challenge with House Dust Mite allergen. Following challenge, patients displayed a clinical nasal response together with enhanced eosinophilia, a cardinal feature of allergic inflammation. Although clinically silent, we observed a distinct, local, innate immune response to allergen in non-allergic individuals, characterized by infiltration of HLA-DRlowCD14+ monocytes expressing anti-microbial genes (S100A8, S100A9, S100A12) as well as transcriptional activation in cDC2, including several inhibitory/tolerogenic genes (NR4A1, IL4I1, ANXA2, TIMP1). The innate response in allergic individuals indicated an inflammatory role for infiltrating HLA-DRhi CD14+ monocytes, CD16+ monocytes, and CD1A+ cDC2 (ALOX15, CD1A, CCL17), in the development/maintenance of an allergic response. Future therapies should address those innate MPS populations, either enhancing or reducing their activity for the treatment of inflammatory airway disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by a consortiumgrant of the Dutch Long Foundation (Grant ID: 5.1.15.015)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All subjects gave written informed consent and research was conducted in compliance with all relevant ethical regulations. Ethical approval was given by Eramsus Medical Centre Ethics Committee in Rotterdam (MEC2016-560).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesall data will be made available upon reasonable requests.